CVS vs RDGT
CVS Health Corp. and Ridgetech, Inc., side by side — 6 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | CVS | RDGT |
|---|---|---|
| Revenue | $402.1B | $120.0M |
| Net income | $1.8B | $10.2M |
| Gross margin | 45.0% | 3.2% |
| Net margin | 0.4% | 8.5% |
| Return on equity | 2.3% | 45.0% |
| Diluted EPS | $1.39 | $1.84 |
| Dividend / share | $2.66 | — |
| Payout ratio | 192.1% | — |
| Free cash flow | $7.8B | $1.1M |
| Equity | $75.2B | $29.6M |
| Net debt / equity | 0.69× | −0.13× |
| Current ratio | 0.84× | 1.74× |
| Revenue CAGR 5y | 8.4% | 0.4% |
| Profit CAGR 5y | −24.4% | — |
CVS bills 3351.4× the revenue of RDGT, and RDGT keeps more of each dollar of revenue as profit (8.5% against 0.4%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
6 years side by side
| Fiscal year | CVS | RDGT |
|---|---|---|
| FY2024 | $372.8B | $120.0M |
| FY2023 | $357.8B | $124.0M |
| FY2022 | $322.5B | $120.2M |
| FY2021 | $292.1B | $164.4M |
| FY2020 | $268.7B | $133.1M |
| FY2019 | $256.8B | $117.3M |
Net income by year
Bottom line
| Fiscal year | CVS | RDGT |
|---|---|---|
| FY2024 | $4.6B | $10.2M |
| FY2023 | $8.3B | $-4.2M |
| FY2022 | $4.3B | $-21.1M |
| FY2021 | $8.0B | $-3.2M |
| FY2020 | $7.2B | $-8.1M |
| FY2019 | $6.6B | $-5.8M |
Advertisement
AdSense · Rectangle 336×280
More in this industry